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Abstract Enterobacter amnigenus (EA76) and Klebsiella
pneumoniae (KP76) isolates with multidrug-resistant
(MDR) patterns were identified from the same patient in
the neurosurgery department of our hospital. An outbreak
of MDR K. pneumoniae h a da l s oo c c u r r e di nt h i s
department. To characterize the resistance mechanism
and molecular epidemiology of these isolates, sequential
experiments including antimicrobial susceptibility testing,
polymerase chain reaction (PCR), plasmid analysis,
pulsed field gel electrophoresis (PFGE), and multilocus
sequence typing (MLST) were performed. EA76 and
KP76 were resistant to all of the antibiotics tested, except
colistin and tigecycline. blaKPC-2, blaTEM-1, blaSHV-12,
blaCTX-M-3, blaCTX-M-14,a n drmtB genes were identified in
both isolates, with blaKPC-2, blaTEM-1, blaCTX-M-14,a n d
rmtB being co-carried on one plasmid in each isolate.
Further analysis showed different restriction patterns
between the two KPC-carrying plasmids. Of the 11
carbapenem-resistant isolates found in the outbreak, all
were resistant to all of the β-lactams tested, with 63.64%
(7/11) also exhibiting resistance to aminoglycosides and
72.73% (8/11) exhibiting resistance to quinolones. PCR
analysis and molecular typing of the 11 K. pneumoniae
strains revealed that the seven aminoglycoside-resistant
isolates shared the same antibiotic-resistant gene pattern
and identical or one-band-difference PFGE profiles relative to
KP76. In addition, all of the eight aminoglycoside-resistant
isolates, including KP76, belonged to the national epidemic
c l o n eS T 1 1 .T h eo v e r a l lr e s u l t si n d i c a t et h ee m e r g e n c eo f
E. amnigenus and outbreak of ST11 K. pneumoniae,w i t h
both co-harboring blaKPC and rmtB genes on a single
plasmid in our neurosurgery wards.
Introduction
Carbapenems are considered to be the first-line therapy
in the treatment of serious infections caused by
extended-spectrum β-lactamase (ESBL)-producing
Enterobacteriaceae [1]. Therefore, the emergence and
prevalent dissemination of carbapenem-resistant Enter-
obacteriaceae presented a serious therapeutic challenge.
Klebsiella pneumoniae carbapenemase (KPC), a member
of the class A carbapenemase family, can hydrolyze all
β-lactam molecules. Since it was first reported in a K.
pneumoniae i s o l a t ei n2 0 0 1[ 2], KPC has disseminated
widely among nosocomial pathogens, especially Enter-
obacteriaceae, and has become the most frequent class A
carbapenemase worldwide [1]. Fortunately, most KPC-
producing isolates are still susceptible to one or more
aminoglycoside antibiotics [3, 4].
Since 2003, the production of 16S rRNA methylase has
been reported to be a new mechanism of aminoglycoside
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DOI 10.1007/s10096-011-1481-xresistance. So far, seven types of methylases have been
identified (ArmA, RmtA, RmtB, RmtC, RmtD, RmtE,
and NpmA) [5–7]. Their presence could confer a pan-
resistance pattern to clinically useful aminoglycosides.
The co-existence of 16S rRNA methylases and various
ESBLs in Enterobacteriaceae has been reported from time
to time [5, 7]. Recently, the co-existence of 16S rRNA
methylase, such as ArmA and RmtB, has also been reported
in KPC-producing pathogens [8, 9]. This co-existence is
quite alarming because additional high-level resistance to
aminoglycosides in KPC-producing isolates and their
potential spread would strongly limit the therapeutic
options.
In previous publications, methylase genes and blaKPC
were reported to be mostly located on different plasmids
[8, 9]. Only Jiang et al. have reported a K. pneumoniae
plasmid co-carrying blaKPC-2 and armA to date [10].
Moreover, when their coexistence is observed, it is mainly
confined to a single isolate, and there has been no
epidemic reported to date.
In the present study, we describe a multiresistant
Enterobacter amnigenus isolate and a K. pneumoniae
isolate from the same patient, both co-carrying blaKPC-2
and rmtB genes on a single plasmid. Further studies
revealed that the multidrug-resistant (MDR) K. pneumo-
niae co-harboring blaKPC-2 and rmtB had disseminated
clonally in our neurosurgery department. To our knowledge,
this is the first report of the detection of blaKPC and rmtB
in E. amnigenus, and also the first documenting of the
emergence and outbreak of MDR K. pneumoniae co-carrying
blaKPC and rmtB on a single plasmid.
Materials and methods
Bacterial strains
Carbapenem-resistant E. amnigenus (EA76) and K. pneu-
moniae (KP76) and an additional 11 non-duplicate
carbapenem-resistant K. pneumoniae isolates were collected
from the neurosurgery department of The First Affiliated
Hospital of the School of Medicine, Zhejiang University,
China, from April 2010 to December 2010. EA76 and
KP76 were isolated from the same patient simultaneously,
with EA76 from blood samples and KP76 from fecal
specimens.Theother11carbapenem-resistantK. pneumoniae
strains were obtained from the following specimens:
lower respiratory tract (LRT) (n=7), upper respiratory
tract (URT) (n=1),blood(n=1), cerebrospinal fluid (CSF)
(n=1), and secretion (n=1). Azide-resistant Escherichia
coli J53 and E. coli DH5α cells (TAKARA, China) were
used as recipients in conjunction and transformation
experiments, respectively.
Antimicrobial susceptibility testing
Minimal inhibitory concentrations (MICs) of various anti-
biotics for KP76, EA76, and their E. coli transformants were
determined with E-test strips according to the manufacturer’s
instructions (AB Biodisk, Solna, Sweden). The MICs for the
other 11 carbapenem-resistant K. pneumoniae isolates were
performed by the agar dilution method, as described in the
guidelines from the Clinical and Laboratory Standards
Institute (CLSI) [11]. The susceptibility results were inter-
preted according to the CLSI criteria [11]. For tigecycline, the
US Food and Drug Administration (FDA) breakpoint values
for Enterobacteriaceae were used (susceptible: ≤2m g / L ;
resistant: ≥8 mg/L), and a concentration of 4 mg/L was used
as the breakpoint of resistance for colistin [12]. E. coli ATCC
25922 was used as a quality control strain.
Conjugation, transformation, and plasmid analysis
Repeated attempts to transfer carbapenem resistance from
EA76andKP76tosodiumazide-resistantE. coli strain J53 by
a mixed-broth mating procedure were performed. Mueller–
Hinton agar (MHA) containing 0.5 mg/L meropenem and
200 mg/L sodium azide was used to select the trans-
conjugants. Plasmids of EA76 and KP76 were extracted with
the QIAGEN Plasmid Midi Kit (Qiagen, Germany) and
transformed into competent E. coli DH5α (TAKARA,
China). MHA plates containing 1 mg/L meropenem were
used to select transformants. KP76-T and EA76-T, confirmed
as blaKPC-positive by polymerase chain reaction (PCR)
analysis, were designated as E. coli transformants of KP76
and EA76, respectively. The plasmids in EA76-T and KP76-
T were extracted with the QIAGEN Plasmid Midi Kit and
digested by BamHΙ, SmaΙ,a n dEcoRΙ (TAKARA, China).
Plasmid DNAs and the digestion products were separated by
gel electrophoresis in 0.8% agarose at 140 V for 2 h.
PCR screening and DNA sequencing
Total DNAs were prepared with the boiling method as
described previously [13], and used as templates for PCR
amplification. Amplification primers for blaKPC, blaTEM,
blaSHV, blaCTX, blaIMP, blaVIM, armA, rmtA, rmtB, qnrA,
qnrB,a n dqnrS were used as described previously [7, 14–16].
All PCR products were sequenced by the dideoxynucleotide
chain-termination method by ABI 377 (ABI, USA) and the
sequences were compared with the nucleotide sequences
from GenBank (http://www.ncbi.nlm.nih.gov/blast/).
Pulsed field gel electrophoresis (PFGE)
Genomic DNAs prepared from KP76 and the other 11 K.
pneumoniae strains were embedded in agarose gel plugs.
1586 Eur J Clin Microbiol Infect Dis (2012) 31:1585–1591After digestion with restricted enzyme XbaΙ (TAKARA,
China), DNA fragments were separated using a CHEF-
MapperXAPFGEsystem(Bio-Rad,USA)for23hat6 V/cm
and 14°C, with a pulse angle of 120° and pulse times from 5 s
to 35 s. PFGE profiles were analyzed visually [17].
Multilocus sequence typing (MLST)
Multilocus sequence typing (MLST) with seven housekeeping
genes (gapA, infB, mdh, pgi, phoE, rpoB,a n dtonB)w a s
carried out for all K. pneumoniae isolates, including KP76,
according to protocols provided on the MLST website for K.
pneumoniae (http://www.pasteur.fr/recherche/genopole/PF8/
mlst/Kpneumoniae.html).
Results
Antimicrobial susceptibility testing
EA76 and KP76 were resistant to almost all of the
antimicrobial agents tested, including cephalosporins,
imipenem, meropenem, amikacin, gentamicin, and cipro-
floxacin, but they were susceptible to colistin and
tigecycline (Table 1). Their E. coli transformants gained
a β-lactam resistance pattern with elevated MICs of
carbapenems. The MIC of ertapenem for EA76-T was as
high as 16 mg/L. In addition, aminoglycoside resistance
was also transferred to EA76-T and KP76-T.
The other 11 carbapenem-resistant K. pneumoniae
isolates showed complete resistance to all of the β-lactams
tested as well. Of them, eight were also resistant to
ciprofloxacin and seven were highly resistant to amikacin.
Moreover, all of the seven amikacin-resistant isolates
were classified into the ciprofloxacin-resistant group. All
of the 11 isolates were susceptible to colistin and
tigecycline (Table 1).
Conjugation, transformation, and plasmid analysis
Repeated attempts to transfer carbapenem resistance from
EA76 and KP76 to sodium azide-resistant E. coli strain J53
were unsuccessful. Two plasmids were extracted from
EA76 and KP76, respectively. The larger plasmid extracted
from each strain (both ~54 kb) was transformed into E. coli
DH5α (Fig. 1a). Restriction analysis of plasmid DNAs
showed different patterns between the two transformants,
EA76-T and KP76-T (Fig. 1b).
PCR screening and DNA sequencing
EA76andKP76 were positive forblaKPC-2, blaTEM-1, blaSHV-12,
blaCTX-M-3, blaCTX-M-14,a n drmtB genes, whereas EA76-T
and KP76-Twere positive for blaKPC-2, blaTEM-1, blaCTX-M-14,
and rmtB genes. This indicates that blaKPC-2 co-existed with
blaTEM-1, blaCTX-M-14,a n drmtB on a single plasmid in both
KP76 and EA76 strains. Of the other 11 K. pneumoniae
isolates, all seven amikacin-resistant isolates shared an
identical resistance gene profile as KP76, whereas two of
the four amikacin-susceptible isolates harbored all of the
genes found in KP76, with the exception of rmtB.T h e
remaining two amikacin-susceptible isolates (KP45 and
KP54) harbored blaVIM-1 carbapenemase gene rather than
blaKPC. KP45 also carried blaTEM-1 and blaCTX-M-10,w h i l e
KP54 carried blaSHV-12 and blaCTX-M-56.N oqnr genes were
detected in any of the screened isolates.
PFGE
PFGE profile analysis revealed that 9 of the 11 K.
pneumoniae isolates had identical or one-band-difference
patterns relative to KP76. The remaining two isolates
(KP45 and KP54), which were positive for blaVIM-1, had
distinct PFGE patterns (Fig. 2).
MLST
MLST showed three sequence types (STs) based on the
analysis of the seven housekeeping genes in the 12 K.
pneumoniae isolates. Of the three sequence types, ST11
was the dominant type and was detected in ten isolates,
including KP76. The remaining two isolates, KP45 and
K P 5 4 ,w e r ef o u n dt ob e l o n gt oS T 4 9 4a n dS T 2 3 ,
respectively. These MLST results were in accordance with
our PFGE findings. The nine ST11 isolates belonged to one
PFGE type, and the ST494 and ST23 isolates belonged to
two distinct PFGE types.
Discussion
To our knowledge, this is the first report of an E.
amnigenus isolate that is resistant to both carbapenems
and aminoglycosides. E. amnigenus is a Gram-negative
aerobic bacillus of the family Enterobacteriaceae. They are
ubiquitous in nature and have been occasionally isolated
from clinical specimens, such as sputum, wound, blood,
and feces [18]. In 2006, an epidemic of post-cataract
surgery endophthalmitis was reported to be caused by this
pathogen in India [19]. E. amnigenus has been reported to
be fully susceptible to almost all antimicrobial agents that
are generally active against Enterobacteriaceae, including
aminoglycosides, most β-lactams, fluoroquinolones,
chloramphenicol, and nitrofurantoin [20]. Here, we reported
an E. amnigenus isolate co-carrying blaKPC-2, blaTEM-1,
blaSHV-12, blaCTX-M-3, blaCTX-M-14,a n drmtB genes, with
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1588 Eur J Clin Microbiol Infect Dis (2012) 31:1585–1591blaKPC-2, blaTEM-1, blaCTX-M-14,a n drmtB on the same
plasmid. This isolate was resistant to almost all of the
antibiotics tested, except tigecycline and colistin.
Therefore, antibiotic regimens for infections involving
this pathogen would become rather limited if this
multiresistant isolate were to become disseminated. In
addition, due to their presence in the environment, the
acquisition and accumulation of resistance determinants
could make E. amnigenus a potential natural reservoir for
these determinants.
The EA76 and KP76 isolates that were co-carrying
blaKPC and rmtB were from the same patient. Their
KPC-producing plasmids were of the same size and
shared an identical resistance determinant profile.
Nevertheless, restriction analysis of the two KPC-producing
plasmids showed different patterns. Further screening of
carbapenem-susceptible E. amnigenus isolates from fecal
specimens of the same patient were unsuccessful. These
results together argue against our initial expectation that
EA76 obtained its blaKPC gene directly from KP76 via the
in vivo transmission of a co-harboring plasmid as
described previously [21]. It is possible that EA76
acquired the blaKPC gene via the mobility of transposon.
Since blaKPC genes were reported to be located within a
roughly 10-kb Tn-3-type transposon, Tn4401,w h i c hc a n
facilitate their mobility between different clones of the
same species or even between clones of different genera
[1]. Or, perhaps most likely, EA76 could have acquired
the KPC-producing plasmid elsewhere, given that
KPC-producing K. pneumoniae were known to be
disseminated widely in our hospital before the isolation
of EA76 (data unpublished).
We found that 7 (63.64%) of the 11 other carbapenem-
resistant K. pneumoniae isolates from our neurosurgery
wards were also highly resistant to aminoglycosides. PCR
analysis revealed that these seven isolates had identical
Fig. 2 Pulsed field gel electrophoresis (PFGE) of XbaΙ-digested
DNAs of K. pneumoniae isolates from our neurosurgery wards. M, λ
DNA ladder; lane 1, KP31; lane 2, KP34; lane 3, KP35; lane 4,
KP45; lane 5, KP48; lane 6, KP54; lane 7, KP86; lane 8, KP98; lane
9, KP104; lane 10, KP111; lane 11, KP215; and lane 12, KP76
Fig. 1 a Plasmid DNAs profiles
of EA76, KP76, EA76-T,
and KP76-T. M, E. coli V517
(used as a standard for plasmid
size); lane 1, EA76; lane 2,
KP76; lane 3, EA76-T; and
lane 4, KP76-T. b Restriction
patterns of Klebsiella
pneumoniae carbapenemase
(KPC)-producing plasmid
DNAs from EA76-T and
KP76-T. M, 1-kb DNA ladder;
lanes 1, 3, and 5, EA76-T;
lanes 2, 4, and 6, KP76-T.
Plasmid DNAs were digested
with BamHΙ, SmaΙ, and EcoRΙ
Eur J Clin Microbiol Infect Dis (2012) 31:1585–1591 1589antimicrobial gene profiles as KP76. PFGE revealed that
six of these seven isolates shared a common identical
PFGE profile with KP76, whereas the remaining isolate
showed a one-band-difference profile (Fig. 2). MLST
analysis showed that all seven of these isolates together
with KP76 belonged to ST11, which is also the dominant
clone of KPC-producing K. pneumoniae in China [22].
These observations strongly suggest that the ST11 K.
pneumoniae isolates containing blaKPC-2 and rmtB on a
single plasmid had disseminated clonally in our neurosur-
gery wards. Two of the remaining four K. pneumoniae
isolates fell into the same PFGE type as KP76, and
belonged to the ST11 clone as well. They carried the same
resistance genes as KP76, except rmtB. This could partly
indicate that rmtB could have disseminated via the
mobilization of transposon or other transposable elements
between K. pneumoniae isolates as well, since rmtB has
been reported to be located adjacent to mobile genetic
elements [5, 13]. The other two remaining K. pneumoniae
isolates carried totally different resistance genes and
belonged to distinct PFGE and MLST types.
In our study, 9/12 (75%) carbapenem-resistant K.
pneumoniae isolates showed ciprofloxacin resistance,
including all eight KPC–RmtB co-producing isolates.
However, no qnr genes were identified in any of the K.
pneumoniae isolates. Quinolone resistance in these
strains could have been mediated by mutations of the
gyrase and topoisomerase IV genes or by efflux pump
mechanisms.
In conclusion, here, we have reported an E. amnigenus
strain and a K. pneumoniae strain that each co-carried
blaKPC-2 and rmtB on a single plasmid; nevertheless, the
two plasmids were different. Further studies revealed that
the MDR ST11 K. pneumoniae co-carrying blaKPC-2 and
rmtB had disseminated widely in our neurosurgery wards.
The co-carriage of various antibiotic resistance determi-
nants on one plasmid can provide survival advantages and
evolutionary benefits to bacteria in an antibiotic-rich
environment, and facilitate their wide spread. In addition,
it can also facilitate the co-transmission of various
competent resistance determinants among different patho-
gens. These observations, together with the fact that few
therapeutic options are available for these infections,
compel us to take urgent actions to contain this outbreak
and the persistent spread of KPC–RmtB co-producing K.
pneumoniae in the hospital setting.
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